EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Butyrate, IL‐4, and EP4 Receptors: A Triad of Colorectal Homeostasis, Protecting Against Onset of Cancer and IBD?

Hiromichi Fujino iD

BioEssays · 2025-09 · 47 (9)

DOI: 10.1002/bies.70046 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift BioEssays, online erschienen am 23.07.2025. Verfasst von Hiromichi Fujino. Beteiligte Einrichtung: Department of Pharmacology for Life Sciences, Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences, Tokushima Universi…. Hauptthemen laut MEDLINE: Receptors, Prostaglandin E, EP4 Subtype, Colorectal Neoplasms, Inflammatory Bowel Diseases, Interleukin-4. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In this article, onset mechanisms of colorectal cancer and intestinal bowel diseases (IBD) are postulated to involve the aberrant expression/hyper‐activation of E‐type prostanoid 4 (EP4) receptors. Although prostaglandin E 2 and EP4 receptors are important factors for maintaining colorectal homeostasis, their mediated signaling is also considered to be involved in the etiology of severe intestinal diseases. To prevent uncontrollable activations of EP4 receptors, two safety factors are proposed: butyrate as an external safety factor and interleukin (IL)‐4 as an internal safety factor. Thus, for maintaining vulnerable colorectal homeostasis, the levels of EP4 receptors, butyrate, and IL‐4 are proposed as an important triad for protecting against development/onset risks of, at least, EP4 receptor‐mediated cancer and IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Prostaglandin E, EP4 SubtypeColorectal NeoplasmsInflammatory Bowel DiseasesInterleukin-4ButyratesColonHumansHomeostasisAnimalsSignal Transduction

Stichwörter der Autor:innen

EP4 receptorsIBDbutyratecolorectal cancercolorectal homeostasisinterleukin‐4prostaglandin E2

Substanzen

Receptors, Prostaglandin E, EP4 SubtypeInterleukin-4Butyrates

Autor:innen und Institutionen

  • Department of Pharmacology for Life Sciences, Graduate School of Pharmaceutical Sciences & Graduate School of Biomedical Sciences, Tokushima University, Tokushima, Japan.

ORCID-Profile: Hiromichi Fujino

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Fujino, H. (2025). Butyrate, IL‐4, and EP4 Receptors: A Triad of Colorectal Homeostasis, Protecting Against Onset of Cancer and IBD?. BioEssays, 47(9). https://doi.org/10.1002/bies.70046

Vancouver

Fujino H. Butyrate, IL‐4, and EP4 Receptors: A Triad of Colorectal Homeostasis, Protecting Against Onset of Cancer and IBD?. BioEssays. 2025;47(9). doi:10.1002/bies.70046

BibTeX
@article{Fujino2025,
  author = {Fujino, Hiromichi},
  title = {Butyrate, IL‐4, and EP4 Receptors: A Triad of Colorectal Homeostasis, Protecting Against Onset of Cancer and IBD?},
  journal = {BioEssays},
  year = {2025},
  volume = {47},
  number = {9},
  doi = {10.1002/bies.70046}
}
Kostenlos starten →